“This” drug can boost survival of head and neck cancer, reveals Tata Memorial Hospital
The long-term follow-up data evaluated 10-year overall survival, with a median follow-up of 8.86 years. July 30, 2024 A study...
neck cancer
The long-term follow-up data evaluated 10-year overall survival, with a median follow-up of 8.86 years. July 30, 2024 A study...
